Valuation: China Isotope & Radiation Corporation

Market Cap 4.74B 5.49B 700M 615M 572M 526M 986M 67.76B 1B 6.84B 2.67B 33.05B 2.63B 2.57B 115B P/E 2024
8.03x
P/E 2025 17.7x
Enterprise Value 4.86B 5.62B 717M 631M 586M 539M 1.01B 69.45B 1.03B 7.01B 2.73B 33.88B 2.69B 2.63B 118B EV / Sales 2024
0.42x
EV / Sales 2025 0.82x
Free-Float
91.21%
Yield 2024
3.74%
Yield 2025 1.69%
07-06 China Isotope to Form JV With Associate MT
07-03 China Isotope & Radiation Corporation and CNNC Yuanke Enter into Shareholders? Agreement to Establish Joint Venture Company CNNC Fuyuan CI
06-18 China Isotope & Radiation Corporation Approves Final Dividend for the Year Ended 31 December 2025, Payable on Before 17 August 2026 CI
06-18 China Isotope & Radiation Corporation Appoints Zhang Guoliang as A Member of Legal Affairs Committee of the Board and A Member of Science and Technology Innovation Committee of the Board CI
05-27 China Isotope Proposes Auditor Change MT
05-26 China Isotope & Radiation Corporation Announces Ma Xiaoyu Resignation of Ma Xiaoyu as an Executive Director Member of the Legal Affairs Committee Science and Technology Innovation Committee, Effective May 26, 2026 CI
03-27 China Isotope & Radiation final cash dividend of RMB0.2264 per share RE
03-27 China Isotope & Radiation Corporation Proposes Final Dividend for the Year Ended December 31, 2025, Payable Before 17 August 2026 CI
03-27 China Isotope & Radiation Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-19 China Isotope & Radiation to buy 51% stake in Hunan Huifeng Engineering Detection RE
03-13 China Isotope & Radiation Corporation, Zhonghe Headway and the People?s Government of Maoming Municipality Enter Strategic Cooperation Agreement CI
03-13 China Isotope & Radiation says co and Zhonghe Headway enter strategic cooperation agreement with Maoming municipality RE
03-02 China Isotope & Radiation's Unit Gets China Nod for Market Launch of Breath Analyzer MT
1 day+1.72%
1 week+0.59%
Current month-2.00%
1 month-8.78%
3 months-8.78%
6 months-20.75%
Current year-15.10%
1 week 16.66
Extreme 16.66
17.77
1 month 16.5
Extreme 16.5
18.73
Current year 16.5
Extreme 16.5
24.28
1 year 15.2
Extreme 15.2
25
3 years 9.03
Extreme 9.03
25
5 years 9.03
Extreme 9.03
29.95
10 years 9.03
Extreme 9.03
35.4
Manager TitleAgeSince
Chief Executive Officer 55 01/08/2024
Corporate Secretary - 29/08/2024
Corporate Secretary - 29/08/2024
Director TitleAgeSince
Director/Board Member 64 29/06/2023
Director/Board Member 46 24/02/2021
Director/Board Member 57 21/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
+1.72%+0.59%+5.21%+27.23% 688M
+0.22%-2.77%+231.60%+307.54% 19.99B
-1.22%-5.09%-43.44%-27.67% 9.4B
-1.06%-1.86%+40.70%+22.17% 6.81B
+1.42%+6.70%+248.46%-20.72% 5.97B
-1.59%+8.49%-13.14%-23.02% 5.62B
-10.00%+9.69%+88.17%+110.73% 5.06B
+0.91%-6.01%-48.42% - 4.35B
-0.27%-4.24%-26.67%-28.93% 4.05B
-1.68%-0.86%-16.61%-39.76% 2.76B
Average -1.15%-2.56%+46.59%+36.40% 6.47B
Weighted average by Cap. -1.01%-3.55%+92.63%+101.68%

Financials

2024 2025
Net sales 7.57B 8.77B 1.12B 984M 914M 840M 1.58B 108B 1.6B 10.93B 4.26B 52.82B 4.2B 4.11B 183B 7.19B 8.32B 1.06B 933M 867M 797M 1.5B 103B 1.52B 10.37B 4.04B 50.12B 3.98B 3.9B 174B
Net income 407M 471M 60.03M 52.8M 49.05M 45.11M 84.6M 5.81B 86.12M 587M 229M 2.84B 225M 221M 9.84B 327M 379M 48.34M 42.51M 39.49M 36.32M 68.12M 4.68B 69.34M 472M 184M 2.28B 181M 178M 7.92B
Net Debt -109M -126M -16.08M -14.14M -13.14M -12.08M -22.66M -1.56B -23.07M -157M -61.29M -760M -60.37M -59.07M -2.64B 119M 138M 17.54M 15.43M 14.33M 13.18M 24.72M 1.7B 25.17M 171M 66.86M 829M 65.86M 64.44M 2.88B
Logo China Isotope & Radiation Corporation
China Isotope & Radiation Corp is a China-based company mainly engaged in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products. The Company operates five business segments. Pharmaceuticals segment is engaged in providing imaging diagnostic and therapeutic radiopharmaceuticals, urea breath test (UBT) kits and analyzers and in vitro diagnostic reagents and kits. Radioactive Source Products segment is engaged in providing various medical and industrial radioactive sources products as well as provision of related technical services. Irradiation segment is engaged in providing sterilization services. Radiation Therapy Equipment and Related Services segment is engaged in manufacturing Radiation therapy equipment. Other Businesses segment is engaged in providing trade services in relation to imported radioactive source, medical nuclides, imported radiopharmaceuticals, and other products.
Employees
3,578
Date Price Change Volume
23/07/26 HK$17.15 +1.72% 33,800
22/07/26 HK$16.86 -1.00% 83,600
21/07/26 HK$17.03 +0.18% 54,000
20/07/26 HK$17.00 +1.19% 36,400
17/07/26 HK$16.80 -4.49% 294,400

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1763 Stock